Prediction of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint inhibitors based on clinical and hematological markers: Real-world evidence

JOURNAL ARTICLE published July 2022 in Experimental Cell Research

Research funded by Tianjin Medical University (2018YFC1313400) | National Natural Science Foundation of China (81872166,U20A20375)

Authors: Huiru Xu | Huijing Feng | Weihong Zhang | Feng Wei | Li Zhou | Liang Liu | Yu Zhao | Yingge Lv | Xiuhuan Shi | Junping Zhang | Xiubao Ren